Former president of AstraZeneca Japan becomes global oncology head

UK-based AstraZeneca has announced that David Fredrickson has became executive vice president and global head of the company’s oncology business.

Mr Fredrickson was formerly the president and representative director of AstraZeneca Japan. He joined the company in 2014 as VP of oncology, infectious disease and neuroscience.

His career in the pharmaceutical and biotech industries started at Genentech in 2005. He occupied several roles within Genentech and later at parent company Roche, until joining AstraZeneca.